msmuthu.phe's picture
Dr. M. S. Muthu
Associate Professor
Department of Pharmaceutical Engineering and Technology, IIT(BHU)
msmuthu.phe@iitbhu.ac.in
9235195928
Area of Interest: 
Pharmaceutical Nanotechnology, Theranostics, Cancer Nanomedicine

E-mail: msmuthu.phe@itbhu.ac.in           
            muthubits@rediffmail.com

EDUCATION:

  • B Pharm.(2002): S.B.College of Pharmacy, Dr.M.G.R.Medical University, Tamil Nadu.

  • M Pharm.(2004): Faculty of Pharmacy, Birla Institute of Technology & Science, Pilani.

  • Ph. D.(2009): Department of Pharmaceutics, IIT (BHU), Varanasi.

  • Post-Doc. (2 Yrs): Faculty of Engineering, National University of Singapore, Singapore

  • Teaching: 14 years
  • Research: 17 years
  • Undergraduate:
        • Industrial Pharmacy
        • Physical Pharmaceutics
        • Clinical Pharmacy
        • Dispensing Pharmacy
        • Microbiology and Biotechnology
  • Postgraduate:
        • Nanopharmaceutics
        • Industrial Pharmacy
        • Drug Regulatory Affairs
        • Advanced Pharmaceutical Analysis
  • Ph. D.
        • Reseach Methodology
        • Advanced Chemical and Bioanalytical Technique 
  • Nanomedicine, Targeted Drug Delivery Systems
  • Theranostic Drug Delivery for Brain Cancer
  • Theranostic Drug Delivery for Tuberculosis
  • Theranostic Drug Delivery for Breast cancer
  • Targeted Drug Delivery Systems for Cardiovascular diseases
S.No. Project title Scheme, Funding agency and Duration Amount P.I. or Co.P.I. Status
1. Studies on micelles loaded with paliperidone palmitate UGC-XI Plan Scheme, No. 4121, 2011-2012 1 Lakh P.I. Completed
2. Transferrin receptor targeted Vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats SERB, DST, India
(FT/SR/LS-132/2011)
2012-2015
24.82 Lakh P.I. Completed
3. Polymeric nanoparticles as drug delivery systems for effective cancer therapy DST, India SR/BY/L-41/09, 2010-2011 17.43 Lakh P.I. Completed
4. Molecular biomaterials for brain targeted nano drug delivery DBT-CREST Awards/26/MSM/2012-13, 2013-2014 23 Lakh P.I. Completed
5. TPGS-chitosan nanoparticles for cancer therapy: formulation, characterization and in-vitro fluorescence study Institute Seed Money,
IIT-BHU
10 Lakh P.I. Completed
6. Targeted theranostic nanomedicine for brain cancer therapy R&D/BIRAC/SGAward/Phe/17-18/31 15 Lakh P.I. Completed
7. Chitosan-folate cross-linked TPGS nanomedicine for site specific cancer therapy Institute Research Support,
IIT-BHU
15 Lakh P.I. Completed
8. Self-assembled smart nano medicine for targeted therapy of advanced non-small cell lung cancer ICMR
 
Project ID: 2020-3011
21.27 Lakh P.I Approved
9.  
Defining the AMR burden of antimicrobial manufacturing waste in Puducherry and Chennai
 
 
DBT, International Cooperation, Indo-UK Project
 
 
106.50 Lakh
 
P.I Ongoing
  Total    219 Lakh    
 
Papers Published (National & International) : 87
  • International                                                      :  80 
  • National                                                              :  07
  • Cumulative impact factor                                 : 390
  • Average impact factor                                       : 4.6
  • h-index                                                                : 36                                         
  • RG Score                                                            : 36.85                                                            
  • Citations                                                             : 3755

 

               Title Authors Journal Volume Page Year
  1. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials.
Muthu, M.S., Kulkarni, S.A., Raju, A, and Feng, S.S. Biomaterials
 
Impact Factor: 12.48
33 3494-3501 2012
  1. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success. 
Muthu, M.S and Feng, S.S. Expert Opinion on Drug Delivery
 
Impact Factor: 6.648
10 (2) 151-155 2013
  1. Nanotheranostics – Application and further development of nanomedicine strategies for advanced theranostics.
Muthu, M.S, Leong D.T, Mei L, and Feng, S.S. Theranostics
 
Impact Factor: 11.56
4 (6) 660-677 2014
  1. Nanotheranostics: advanced nanomedicine for integration of diagnosis and therapy. 
Muthu, M.S., Mei, L, and Feng, S.S. Nanomedicine UK
 
Impact Factor: 5.307
9 (9) 1277-1280 2014
  1. Theranostic Vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters.
Muthu, M.S., Kutty, R.V., Luo, Z., Xie, J and Feng, S.S. Biomaterials
 
Impact Factor: 12.48
39 3494-3501 2015
  1. Theranostic nanomedicine of gold nanoclusters: emerging platform for cancer diagnosis and therapy.
Muthu, M.S., Agrawal, P, and Singh, S Nanomedicine UK
Impact Factor: 5.307
11 327-330 2016
  1. Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulations and brain theranostics. 
Sonali, Singh, R.P., Singh, N., Sharma, G., Vijayakumar, M.R., Koch, B., Sanjay, S., Singh, U., Dash, D., Pandey, B.L., Muthu, M.S. Drug Delivery
 
Impact Factor: 6.419
23 1261-1271 2016
  1. RGD-TPGS decorated theranostic liposomes for brain-targeted delivery.
Sonali, Singh, R.P., Sharma, G., Kumari, L., Koch, B., Singh, S.,Bharti, S, Rajnikanth, P.S., Muthu, M.S. Colloids and Surfaces B: Biointerfaces
 
Impact Factor: 5.268
147 129-141. 2016
  1. Reality check for nanomaterials-mediated therapy with 3D biomimetic culture systems.
Tay C.Y., Muthu M.S., Chia S.L., Nguyen K.T., Feng,S.S., Leong D.T. Advanced Functional Materials.
Impact Factor: 18.81
26 4046-4065 2016
  1. Nanotheranostics: Emerging strategies for early diagnosis and therapy of brain cancer.
Sonali, Viswanadh M.K., Singh, R.P., Agrawal, P., Mehata, A.K., Pawde, D.M., Sonkar, R., Muthu. M.S. Nanotheranostics 2(1) 70-86 2018

No.

PUBLICATION DETAILS

Impact Factor
2020

A. INTERNATIONAL

  1.  

Singh M, Rana NK, Muthu MS, Jha A, Baul TS, Koch B. Enhanced in vitro therapeutic efficacy of triphenytin (IV) loaded vitamin E TPGS against breast cancer therapy. Materials Today Communications. 2022 Feb 11:103256.

3.383

  1.  

Vikas, Viswanadh MK, Mehata AK, Sharma V, Priya V, Varshney N, Mahto SK, Muthu MS (2021). Bioadhesive chitosan nanoparticles: Dual targeting and pharmacokinetic aspects for advanced lung cancer treatment. Carbohydrate Polymers. 274: 118617.

9.381

  1.  

Mehata AK, Viswanadh MK, Priya V, Vikas, Muthu MS. Harnessing immunological targets for COVID-19 immunotherapy. Future Virology. 2021 Sep;16(9):619-40.

1.831

  1.  

Viswanadh MK, Agrawal N, Azad S, Jha A, Poddar S, Mahto SK, Muthu MS (2021). Novel redox-sensitive thiolated TPGS based nanoparticles for EGFR targeted lung cancer therapy. International Journal of Pharmaceutics. 602:120652.

5.875

  1.  

Singh SK, Muthu MS, Revand R, Mandal MB. Intra-arterial Instillation of a Nociceptive Agent Modulates Cardiorespiratory Parameters Involving 5-HT3 and TRPV1 Receptors in Anesthetized Rats. Cardiovascular & Haematological Disorders-Drug Targets (Formerly Current Drug Targets-Cardiovascular & Hematological Disorders). 2021 Mar 1;21(1):46-54.

--

  1.  

Alla SK, Gangwar A, Shaw SK, Viswanadh MK, Neogi K, Muthu MS, Gupta N, Meena SS, Kollu P, Mandal RK, Prasad NK, (2021). Physical and in-vitro evaluation of pure and substituted MxCe1-xO2 (M= Co, Fe or Ti and x= 0.05) magnetic nanoparticles. Ceramics International. 47(7):8812-9.

4.527

  1.  

Priya V, Viswanadh MK, Mehata AK, Jain D, Singh SK, Muthu MS., (2021). Targeted nanotherapeutics in the prophylaxis and treatment of thrombosis. Nanomedicine. 2021 Mar;16(13):1153-76.

5.3

  1.  

Pawde DM, Viswanadh MK, Mehata AK, Sonkar R, Poddar S, Burande AS, Jha A, Vajanthri KY, Mahto SK, Dustakeer VA, Muthu MS., (2020).. Mannose receptor targeted bioadhesive chitosan nanoparticles of clofazimine for effective therapy of tuberculosis. Saudi Pharmaceutical Journal. 28(12):1616-25.

4.330

  1.  

Sonkar R, Sonali, Jha A., Viswanadh MK, Narendra, Pawde DM, KK Patel., Singh M, Koch B, MS Muthu., (2021). Gold liposomes for brain-targeted drug delivery and bioimaging. Mater Sci Eng C Mater Biol Appl. 120, 111652.

7.328

  1.  

Viswanadh, M.K., Vikas, Jha A., SK Reddy Adena, Mehata, A.K., Priya, V., K Neogi, Poddar S., Mahto S.K., Muthu, M.S., (2020). Formulation and in-vivo efficacy study of cetuximab decorated targeted bioadhesive nanomedicine for NSCLC therapy. Nanomedicine UK. 15 (24), 2345-2367

5.3

  1.  

Narendra, Mehata AK, Viswanadh MK, Sonkar R, Pawde DM, Priya V, Singh M, Koch B, S Muthu M. Formulation and in vitro evaluation of upconversion nanoparticle-loaded liposomes for brain cancer. Therapeutic Delivery. 2020 Sep;11(9):557-71.

3.70
Cite   Score

  1.  

Mehata AK, Dehari D, Ayyannan SR, Muthu MS. X-ray powder diffraction spectroscopy as a robust tool in early predicting bioavailability of pharmaceutical formulation containing polymorphic drug substance. Drug Delivery Letters. 2020 Sep 1;10(3):250-4.

--

  1.  

Ankita SB., Jha A., Viswanadh M.K., Mehata A.K., Poddar S., Mahto S.K., Muthu M.S. (2020) EGFR targeted paclitaxel and piperine co-loaded liposomes for treatment of triple negative breast cancer. AAPS Pharm Sci Tech. USA. (2020) 21:151

3.246

  1.  

Mehata, A.K., Viswanadh, M.K., Priya, V., Vikas, Muthu, M.S., (2020). Dendritic cells targeted theranostic nanomedicine: advanced cancer nanotechnology for diagnosis and therapy. Nanomedicine UK. 15(2020), 947-949s.

5.3.

  1.  

Jha A., Viswanadh M.K., Burande B.S., Mehata A.K., Poddar S., Yadav K., Mahto S.K., Parmar A.S., Muthu M.S. (2020) DNA biodots based targeted theranostic nanomedicine for the imaging and treatment of non-small cell lung cancer. International Journal of Biological Macromolecules. 150 (2020) 413–425.

6.953

  1.  

Gangwar, A., Varghese, S.S., Meena, S.S., Viswanadh, M.K., Neogi, K., Muthu, M.S. and Prasad, N.K., Physical and in vitro evaluation of ultrafine cohenite particles for the prospective magnetic hyperthermia application. J Mater Sci: Mater Electron 31, 10772–10782 (2020).

2.478

  1.  

Gangwar A, Varghese SS, Meena SS, Prajapat CL, Viswanadh MK, Neogi K, Muthu MS, Prasad NK. Physical and in-vitro evaluation of ϵ-Fe3N@ Fe3O4 nanoparticles for bioapplications. Ceramics International. 2020 Jun 1;46(8):10952-62.

4.527

  1.  

Gangwar A, Kumar S, Meena SS, Sharma A, Viswanadh MK, Neogi K, Muthu MS, Prasad NK. Structural and in-vitro assessment of ZnxFe3− xC (0≤ x≤ 1) nanoparticles as magnetic biomaterials. Applied Surface Science. 2020 Apr 15;509:144891.

6.707

  1.  

Vikas, Viswanadh MK, Priya V, Mehata AK, Muthu MS. What are the unexplored facts about nanomicelles formed from docetaxel clinical injection? Therapeutic Delivery. 11 (1), 801-803

3.70
Cite   Score

  1.  

Patel, K.K., Surekha, D.B., Tripathi, M., Anjum, M.M., Muthu, M.S., Tilak, R., Agrawal, A.K. and Singh, S., 2019. Antibiofilm potential of silver sulfadiazine-loaded nanoparticle formulations: a study on the effect of DNase-I on microbial biofilm and wound healing activity. Molecular pharmaceutics, 16(9), pp.3916-3925.

  4.939

  1.  

Mehata A.K, Bharti S, Singh P, Viswanadh M.K, Kumari L, Agrawal P, Singh S, Koch B, Muthu. M.S. (2019): Trastuzumab decorated TPGS-g-chitosan nanoparticles for targeted breast cancer therapy. Colloids and Surfaces B: Biointerfaces. 173, 366-377.

  5.268

  1.  

Muthu, M.S., and Sonali (2018): Stem cell therapy and nanomedicine for Alzheimier’s disease. Research and Reviews: Journal of Pharmacology and Toxicological Studies. 6(2), 14-17.

     --

  1.  

Viswanadh, M.K., Muthu, M.S. (2018): Targeted bioadhesive nanomedicine: An
effective approach for synergistic drug delivery to cancers. Nanomedicine (Lond.) 13(12), 1401–1403.

 5.3

  1.  

Sonali, Viswanadh M.K., Singh, R.P., Agrawal, P., Mehata, A.K., Pawde, D.M., Narendra., Sonkar, R., Muthu. M.S. (2018): Nanotheranostics: Emerging strategies for early diagnosis and therapy of brain cancer. Nanotheranostics. 2(1), 70-86.

     --

  1.  

Singh R.P., Sharma G., Sonali., Muthu M.S. (2017): Chitosan-folate decorated carbon nanotubes for site specific lung cancer delivery. Mater Sci Eng C Mater Biol Appl. 77, 446-458.

 7.328

  1.  

Muthu M.S., Mehata, A.K., Viswanadh, M.K. (2017): Upconversion nanotheranostics: emerging designs for integration of diagnosis and therapy. Nanomedicine 12(6), 577-580.

 5.3

  1.  

Agrawal, P., Singh, R.P., Sonali, Kumari, L., Mehata, A.K., Sharma, G., Singh, S., Rajesh, C.V., Koch, B., Pandey, B.L., Muthu, M.S. (2017): TPGS-chitosan crosslinked targeted nanoparticles for effective brain cancer therapy. Material Science and Engineering: C.  74, 167-176.

7.328

  1.  

Agrawal, P., Sonali, Singh, R.P., Sharma, G., Koch, B., Singh, S., Mehata, A.K., Rajesh, C.V., Pandey, B.L., Muthu, M.S. (2017): Bioadhesive micelles of D-α-tocopheryl polyethylene glycol succinate 1000: synergism of chitosan and transferrin in targeted drug delivery. Colloids and Surfaces B: Biointerfaces. 152, 277-288.

5.268

  1.  

Mishra, B., Upadhyay, M., Reddy Adena S.K., Vasant, B.G., Muthu M.S. (2017): Hydrogels: an introduction to a controlled drug delivery device, synthesis and application in drug delivery and tissue engineering. Austin Journal of Biomedical Engineering. 4 (1), 1037.

    ---

  1.  

Sonali, Singh, R.P., Sharma, G., Kumari, L., Koch, B., Singh, S.,Bharti, S, Rajnikanth, P.S., Pandey, B.L., Muthu, M.S. (2016): RGD-TPGS decorated theranostic liposomes for brain targeted delivery. Colloids and Surfaces B: Biointerfaces. 145, 479-491.

5.268

  1.  

Vijayakumar,M.R., Kosuru,R., Singh,S.K., Prasad,C.B., Narayan,G., Muthu,M.S. (2016): Resveratrol loaded PLGA: d-α-tocopheryl polyethylene glycol 1000 succinate blend nanoparticles for brain cancer therapy. RSC Advances. 6, 74254-74268.

  3.361

  1.  

Vijayakumar, M.R., Vajanthri, K.Y., Balavigneshwaran, C.K., Mahto, S.K., Mishra, N., Muthu M.S. and Singh S (2016): Pharmacokinetics, biodistribution, in vitro cytotoxicity and biocompatibility of Vitamin E TPGS coated trans resveratrol liposomes. Colloids and Surfaces B: Biointerfaces. 145, 479-491.

5.268

  1.  

Singh, R.P., Sharma, G., Sonali., Singh, S., Patne, S.C.U., Pandey, B.L., Koch, B., Muthu M.S. (2016): Effects of transferrin conjugated multi-walled carbon nanotubes in lung cancer delivery. Material Science and Engineering: C. C 67, 313-325.

7.328

  1.  

Prakash, S., Muthu, M.S., and Singh, S (2016): Adiponectin enhancers: treatment options for obesity and diabetes. Research and Reviews: Journal of Pharmacology and Toxicological Studies. 4(1), 24-26.

    ---

  1.  

Kaklotar, D., Agrawal, P., Abdulla, A., Singh, R.P., Sonali., Mehata, A.K., Singh, S., Mishra, B., Trigunayat, A., Pandey, B.L., Muthu M.S. (2016): Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycaemic control in diabetes. Nanomedicine 11(11), 1465-1486.

  5.3

  1.  

Tay C.Y., Muthu M.S., Chia S.L., Nguyen K.T., Feng S.S., Leong D.T. (2016): Reality check for nanomaterials-mediated therapy with 3D biomimetic culture systems. Advanced Functional Materials. 26, 4046-4065.

  18.808

  1.  

Sonali, Agrawal, P., Singh R.P., Rajesh, C.V., Sanjay, S., Vijayakumar M.R., Pandey B.L., Muthu, M.S. (2016): Transferrin receptor-targeted vitamin E TPGS micelles for
 brain cancer therapy: preparation, characterization and brain distribution in rats. Drug Delivery. 23, 1788-1798.

  6.419

  1.  

Sonali, Singh, R.P., Singh, N., Sharma, G., Vijayakumar, M.R., Koch, B., Sanjay, S., Singh, U., Dash, D., Pandey, B.L., Muthu, M.S. (2016): Transferrin liposomes of docetaxel for brain targeted cancer applications: formulations and brain theranostics.  Drug Delivery. 23, 1261-71.

  6.419

  1.  

Singh, R.P., Sharma, G., Sonali., Singh, S., Kumar, M., Pandey, B.L., Koch, B., Muthu M.S. (2016): Vitamin E TPGS conjugated carbon nanotubes improved efficacy of docetaxel with safety for lung cancer treatment. Colloids and Surfaces B: Biointerfaces. 141:429-42.

5.268

  1.  

Singh, R.P., Sharma, G., Sonali, Agrawal, P., Pandey, B.L., Koch, B., Muthu, M.S. (2016): Transferrin receptor-targeted PLA-TPGS micelles improved efficacy and safety in docetaxel delivery. International Journal of Biomacromolecules. 83:335-44.

  6.953

  1.  

Muthu, M.S., Agrawal, P and Singh, S (2016): Theranostic nanomedicine of gold nanoclusters: emerging platform for cancer diagnosis and therapy. Nanomedicine UK. 11:327-30.

  5.3

  1.  

Muthu, M.S., Sahu A.K., Sonali., Abdulla, A., Kaklotar, D., Rajesh, C.V., Sanjay, S and Pandey B.L. (2016): Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management. Drug Delivery. 23, 230-37.

  6.419

  1.  

Kumar, D., Muthu, M.S., Pandey, B.L. (2015): Pharmacovigilance Programme in India: current status and its Indian perspectives. Research and Reviews: Journal of Pharmacology and Toxicological Studies. 3(3), 34-36.

     ---

  1.  

Kutty, R.V., Chia, S.L., Setyawati, M.I., Muthu, M.S., Feng, S.S., Leong, D.T. (2015): In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer. Biomaterials. 63, 58-69.

  12.479

  1.  

Muthu, M.S., Kutty, R.V., Luo, Z., Xie, J and Feng, S.S. (2015): Theranostic Vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultra bright gold nanoclusters. Biomaterials. 39, 3494-3501.

  12.479

  1.  

Muthu, M.S., Agrawal, P and Singh, R.P. (2014): Antipsychotic nanomedicine: a successful platform for clinical use.  Nanomedicine UK. 9 (14), 2401-2404.

  5.3

  1.  

Muthu, M.S., Mei, L and Feng, S.S. (2014): Nanotheranostics: advanced nanomedicine for integration of diagnosis and therapy.  Nanomedicine UK. 9 (9), 1277-1280.

  5.3

  1.  

Muthu, M.S, Leong D.T, Mei L and Feng, S.S. (2014): Nanotheranostics – Application and further development of nanomedicine strategies for advanced theranostics. Theranostics. 4 (6), 660-677.

  11.556

  1.  

Kesavan, K., Pandit, JK., Kant S and Muthu, M.S (2013): Positively charged microemulsions of dexamethasone: comparative effects of two co-surfactants on ocular drug delivery and bioavailability. Therapeutic Delivery. 4 (11), 1385-1395.

3.70 Cite Score

  1.  

Muthu, M.S., Abdulla, A. and Pandey B.L. (2013): Major toxicities of carbon nanotubes induced by reactive oxygen species: should we worry about the effects on the lungs, liver and normal cells? Nanomedicine UK. 8 (6), 863-866.

  5.3

  1.  

Raju, A., Muthu, M.S. and Feng, S.S. (2013): Trastuzumab-conjugated Vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel. Expert Opinion on Drug Delivery. 10 (6), 747-760.

   6.648

  1.  

Vijayakumar M.R., Muthu, M.S. and Singh S (2013): Co-polymers of poly (lactic acid) and D-α-tocopheryl polyethylene glycol 1000 succinate based nanomedicines: versatile multifunctional platforms for cancer diagnosis and therapy. Expert Opinion on Drug Delivery. 10 (4), 529-543.

6.648

  1.  

Muthu, M.S and Feng, S.S. (2013): Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.  Expert Opinion on Drug Delivery. 10 (2), 151-155.

  6.648

  1.  

Sahu, AK., Gautam, M.K., Deshmukh, P.T., Kushwah, L.S., Silawat, N., Akbar, Z and Muthu, M.S. (2013): Effect of embelin on lithium-induced nephrogenic diabetes insipidus in albino rats. Asian Pacific Journal of Tropical Disease. S729-S733.

Scopus Indexed

  1.  

Lanjhiyana S.K., Bajpayee P., Kesavan K., Lanjhiyana S and Muthu, M.S. (2013): Chitosan-sodium alginate blended polyelectrolyte complexes as potential multiparticulate carrier system: colon targeted delivery and gamma scintigraphic imaging.  Expert Opinion on Drug Delivery. 10 (1), 5 -15.

  6.648

  1.  

Muthu, M.S (2012): Focus on the development of computer-aided nanomedicine design. Nanomedicine UK. 7(10), 1471-1473.

  5.3

  1.  

Muthu, M.S., Pandey B.L., Sahu, A.K. and Rajesh, C.V. (2012): Emerging patents for cancer-targeted nanomedicines. Pharmaceutical Patent Analyst. 1(2), 113-115.

PubMed Indexed

  1.  

Muthu, M.S., Kulkarni, S.A., Raju, A and Feng, S.S. (2012): Theranostic liposomes of TPGS coating for targeted co delivery of docetaxel and quantum dots. Biomaterials. 33, 3494-3501.

  12.479

  1.  

Muthu, M.S. and Wilson, B. (2012): Challenges posed by the scale-up of nanomedicines.  Nanomedicine UK. 7 (3), 307-309.

  5.3

  1.  

Muthu, M.S., Kulkarni S.A., Yutao L and Feng, S.S. (2012): Development of docetaxel loaded Vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats.  Nanomedicine UK. 7 (3), 353-364.

  5.3

  1.  

Muthu, M.S., Kulkarni, S.A., Xiong, J and Feng, S.S. (2011): Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. International Journal of Pharmaceutics. 421 (2), 332-340.

  5.875

  1.  

Muthu, M.S. and Feng, S.S. (2011): Targeted nanomedicine for the detection and treatment of circulating tumour cells.  Nanomedicine UK. 6 (4), 579-581.

  5.3

  1.  

Wilson, B., Samanta, MK., Muthu, M.S and Vinothapooshan, G. (2011): Design and evaluation of chitosan nanoparticles as novel drug carrier for the delivery of rivastigmine to treat alzheimer’s disease. Therapeutic Delivery. 2 (5), 599-609.

  3.70
Cite Score

  1.  

Muthu, M.S. and Feng, S.S. (2010): Nanopharmacology of liposomes developed for cancer therapy.  Nanomedicine UK. 5(7), 1017-1019.

  5.3

  1.  

Rawat, M.K., Jain, A., Mishra, A., Muthu, M.S and Singh, S. (2010): Effect of lipid matrix on characteristics of repaglinide loaded solid lipid nanoparticles for oral delivery. Therapeutic Delivery. 1(1), 63-73.

3.70
 Cite core

  1.  

Singh, S., Soni, R., Rawat, M.K., Jain, A., Deshpande, S.B., Singh, S.K., and Muthu, M.S. (2010): In vitro and in vivo evaluation of buccal bioadhesive films containing salbutamol sulphate. Chem. Pharm. Bulletin. 58(3), 307-311.

1.645

  1.  

Muthu, M.S. and Wilson, B. (2010): Multifunctional radionanomedicine: a novel platform for effective cancer imaging and therapy.  Nanomedicine UK. 5 (2), 169-171.

5.3

  1.  

Rawat M.K., Jain A., Mishra, A., Muthu M.S., Singh, S. (2010): Development of repaglinide loaded solid lipid nanocarrier: selection of fabrication method. Current Drug Delivery. 7 (1), 44-50.

2.565

  1.  

Muthu, M.S. and Feng, S.S. (2009): Pharmaceutical stability aspects of nanomedicines.  Nanomedicine UK. 4 (8), 857-860.

   5.3

  1.  

Muthu, M.S., Rajesh, C.V., Mishra, A., Singh, S. (2009): Stimulus responsive targeted nanomicelles for effective cancer therapy. Nanomedicine UK. 4(6), 657-667.

 
 5.3

  1.  

Muthu, M.S., Rawat, M.K., Mishra, A., Singh, S. (2009): PLGA nanoparticles formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine (NBM). 5(3), 323-333. (Listed in Science Direct Top 25 Hottest Articles – Rank is 15)

6.458

  1.  

Singh, S., Gajra, B., Muthu, M.S., Rawat, M., (2009): Enhanced transdermal delivery of ketoprofen from bioadhesive gel. Pakistan Journal of Pharmaceutical Sciences. 2(2), 193-198.

0.684

  1.  

Muthu, M.S., Singh, S. (2009): Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine UK. 4(1), 105-118.

 
5.3

  1.  

Muthu, M.S and Singh, S. (2009): Poly (D, L-Lactide) nanosuspension of risperidone for parentral delivery: formulation and in vitro evaluation. Current Drug Delivery. 5(1),62-68.

2.565

  1.  

Sunilson, A.J., Muthu, M.S., Mohan, M.S., Kumari, A.A.G., Thomas, J and Jeyaraj, P. (2008): Antidiabetic activity of MOMORDICA TUBEROSA (ROXB.) tuber extracts. Int J Pharmacol Biol Sci. 2(2), 41-45.

---

  1.  

Muthu, M.S. and Singh, S. (2008): Studies on biodegradable polymeric nanoparticles of risperidone: in-vitro and in-vivo evaluation. Nanomedicine UK. 3(3) 305-319.

 
5.3

  1.  

Singh, S., Jain, S., Muthu, M.S., Tiwari, S., Tilek, R. (2008): Preparation and    evaluation of buccal bioadhesive films containing clotrimazole. AAPS Pharm Sci Tech. USA 9(2), 660-667.

3.246

  1.  

Singh, S., Jain, S., Muthu, M.S and Tilak, R. (2008): Preparation and evaluation of buccal bioadhesive tablets containing clotrimazole. Current Drug Delivery. 5 (2), 133-141.

2.565

  1.  

Singh, S., Mahendra, K., Srivastava, A.K., Garg, A. and Muthu, M.S. (2007): Effect of permeation enhancers on the iontophoretic transport of timolol maleate through rat skin.  Acta Pharmaceutica Sciencia. 49 (3), 235-252.

0.92

  1.  

Singh, S., Singh, J., Muthu, M.S., Balasubramaniam, J and Mishra, B. (2007): Gastroretentive drug delivery of metoclopramide Hcl: formulation and in- vitro evaluation. Current Drug Delivery. 4(4) 269-275.

2.565

  1.  

Singh, S. and Muthu, M.S. (2007): Preparation and characterization of nanoparticles containing an atypical antipsychotic agent. Nanomedicine UK. 2 (2), 233-240.

5.3

 

                                                     B. NATIONAL

 

82.

Sah, A.K., Muthu, M.S., Singh, S: (2017): Poly (D, L, Lactide-co-glycolide) (PLGA): A novel biodegradable polymer for ocular therapeutics. The Pharmstudent. 28, 59-65.

----

83.

Sonali, Singh, R.P., Viswanadh, M.K., Singh, S., Muthu, M.S. (2017): Mesoporous Silica Nanoparticles for Brain Cancer Theranostics. The Pharmstudent. 28, 36–44.

---

84.

Mehata, A.K., Dubey, T., Bhanukiran, K., Dehari, D., Priya, V., Muthu, M.S. (2017): Receptor targeted nanomedicine as emerging platform for brain cancer therapy: an review article. World Journal of Pharmaceutical Research. 6, 487-497.

---
 

85.

Singh, R.P., Sonali, Mehata, A.K., Agrawal, P., Singh, S., Muthu, M.S. (2016): Carbon nanotubes: super-fabric tiny materials as lung cancer theranostics. The Pharmstudent. 27, 55-78.

---
 

86.

Muthu, M.S (2009): Nanoparticles based on PLGA and its co-polymer: An overview. Asian Journal of Pharmaceutics. 3(4), 266-273.

Scopus Indexed

87.

Pandit, J.K., Singh, S and Muthu, M.S. (2006): Controlled release formulations in neurology practice: A review. Annals of Indian Academy of Neurology. 9 (4), 207-216.

  1.383

88.

Singh, S., Singh, J., Muthu, M.S and Mishra, B (2006): Prolonged gastric retention: floating microspheres for oral controlled drug delivery. The Indian Pharmacist. 5
(53), 61-68.

 

 

Research Guidance

Ph.D.               : Completed: 3, Ongoing: 7                                                                             
Ph. D. Scholars under supervision:                                                                                       
1. Matte Kasi Viswanadh                                                                                                         
2. Vikas                                                                                                                         
3. Vishnu Priya                                                                                                                         
4. Abhishesh Kr Mehata
5. Gokul P.
6. Medapatti Nikitha  LaxmiSuseela
7. Ankit Kumar Malik                                                                                                            

                                                                                                                                                 
PG                                 : Completed: 19, Ongoing: 01                                                           
PG Students under supervision:
1. Susanta Kumar Rout

Exploratory Project     : 10
UG                                 : 10
External Fellowships  : RGNF (02-Completed)

 Dr. Muthu'S Lab Alumni                  
 1. Dr. Rahul Pratap Singh               
 2. Dr. Sonali                                      
 3. Dr. Poornima Agrawal                  
 4. Mr. Abhishesh Kumar Mehata       
 5. Mr. Roshan Sonkar                         
 6. Mr. Datta Maroti Pawde                 
 7. Mr. Narendra 
 ​8. Mr. Abhishek Jha
 9. Miss. Ankita Burande
10.Mr. Shaik Azad
11.Miss. Nishi Agrawal 
12. Mr. Amit sankar
13. Mr. Hemendra
14. Miss. Natasha Manner                            

Awards/Honors:

  • Class Topper in B.Pharm. S.B. College of Pharmacy, Sivakasi, Tamilnadu.
  • M.Pharm. GATE Scholarship University Grant Commission, New Delhi.
  • Stipend Cadila Pharmaceuticals Limited, Ahmedabad, Gujarat.
  • Senior Research Fellowship Banaras Hindu University, Varanasi- University Grant Commission, New Delhi, India.
  • BOYSCAST FELLOWSHIP (2009-10) Department of Science and Technology (DST), India.
  • Academic Excellence Award (2012) Institute of Medical Sciences, Banaras Hindu University, Varanasi.
  • DBT-CREST AWARD (2012-13) Department of Biotechnology (DBT), India.
  • IMS-Research Publication Award (2013) Institute of Medical Sciences, Banaras Hindu University, Varanasi.
  • IMS-Research Publication Award (2014) Institute of Medical Sciences, Banaras Hindu University, Varanasi.
  • VICE-CHANCELLOR’S MEDICAL RESEARCH AWARD (2014) Institute of Medical Sciences, Banaras Hindu University, Varanasi.
  • International Faculty Award (VIFA-2016), Venus International Foundation, Chennai, India.
  • Best Young Scientist Award (2016) Pearl Foundation, Madurai, India.
  • BIRAC-DBT- Gandhian Young Technological Innovation (GYTI) Award - 2017.
  •  Ranked top 2% scientist globally, a list compiled by the Stanford University

Recognitions:

  • Cancer Nanotechnology, Nano Drug Delivery Techniques - Workshop, Department of Pharmaceutics, PSG College of Pharmacy, Coimbatore (TN), 27 April, 2012.
  • Nano drug formulations: better options for anti-psychotic and anti-cancer therapy, NASI-Young Scientist Platinum Jubilee Award, National Academy of Sciences, India, Allahabad (UP), 19 July, 2012.
  • Anti-psychotic Nanomedicine and Cancer Theranostics, INSA-Young Scientist Award, Indian National Science Academy, India, New Delhi, April, 2013.
  • Targeted theranostics nanomedicine: formulation, characterization and cancer application. Biomaterials in Medicinal Chemistry National Conference at Department of Natural Chemistry at Madurai Kamaraj University, Madurai, India during 14 April 2017.
  • 2nd Prize for poster presentation, M.Tech. level, Institute Day – 2017, Indian Institute of Technology (BHU), Varanasi -221005.
  • 1 st Prize for poster presentation, NIPiCON – 2018, International conference on “Innovation in Pharmaceutical Research by Interdisciplinary Approach’’ in Nirma Institute of Pharmacy, Ahmedabad, Gujarat.
  • Nanotheranostics: micelles for early diagnosis and therapy of cancer. Nanopharmaceutics and Advanced Drug Delivery held on 17th August 2018 in Dublin, Ireland.

Reviewer for Journals:

  • Biomaterials (Publisher – Elsevier, U.S.A)
  • Nanomedicine: Nanotechnology Biology and Medicine (Publisher – Elsevier, U.S.A)
  • Journal of Controlled Release (Publisher – Elsevier, U.S.A)
  • Nanoscience and Nanotechnology Letters (Publisher – American Scientific Publishers)
  • Nanomedicine (Publisher – Future Medicine, U.K)
  • Molecular Pharmaceutics (Publisher – American Chemical Society)
  • International Journal of Pharmaceutics (Publisher – Elsevier, U.S.A)
  • Expert opinion on drug delivery (Publisher – Informa healthcare, USA)
  • Journal of Pharmacy and Pharmacology (Publisher – Wiley, U.K)
  • Drug Delivery (Publisher – Informa healthcare, USA)
  • Therapeutic Delivery (Publisher – Future Science, U.K) and more….

Editor/Editorial board member for Journals:

  • Editor-in-Chief: Research and Reviews: Pharmacology and Toxicology Studies
  • ISRN Biomedical imaging (Publisher – Hindawi, U.S.A)
  • ISRN Pharmaceutics (Publisher – Hindawi, U.S.A)
  • ISRN Biomaterials (Publisher – Hindawi, U.S.A)
  • World Journal of Methodology
  • BioMed International (Pharmaceutics – Lead Guest Editor) (Publisher – Hindawi, U.S.A)